UVA Licensing & Ventures Group
UVA Licensing & Ventures Group is an investment firm focused on commercializing innovations developed at the University of Virginia. It plays a crucial role in bridging the gap between academia and the marketplace by identifying promising technologies and managing their licensing and commercialization. The organization supports faculty and researchers in bringing their inventions to market, fostering entrepreneurship, and promoting economic development. Through strategic partnerships and investment strategies, UVA Licensing & Ventures Group aims to enhance the university's impact on society while generating revenue from its intellectual property portfolio.
Top Sectors
Past deals in Intellectual Property
GenEp
Seed Round in 2021
GenEp, Inc. is a pre-clinical stage biotechnology company that focuses on developing therapies for rare genetic epilepsies and other treatment-resistant forms of epilepsy. The company leverages its intellectual property assets to create selective compounds aimed at modulating sodium and other ion channels associated with these conditions. By targeting specific mutations within these channels, GenEp seeks to enable medical professionals to develop effective treatment options tailored to meet the unique medical needs of patients suffering from these challenging disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.